") to Coloplast for total consideration of $463,225,000, of which $456,137,500 would be in cash and $7,087,500 in non-cash consideration, and on June 2, 2006 we completed this sale to Coloplast. 

In connection with the sale, we have entered into a Transition Services Agreement ("TSA") and various supply agreements.  Pursuant to the TSA, we will provide to Coloplast, and Coloplast will provide to us, services including accounting, regulatory, clinical, information technology, customer support, and use of facilities in exchange for specified fees.  Under the supply agreements we will supply various products, including silicone gel-filled testicular...